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7. Metabolic omplications of CF 
I~  Bone mineral density in patients with Cystic Fibrosis of Yaroslavl 
regional center 
I.K. Asherova 1 , O.B. Ershova 2. 1 Child Clinical Hospital 1, 2State Medical 
Academy, Jaroslavl, Russia 
Aims: to assess the frequency of osteopenia n cystic fibrosis (CF) patients and the 
clinical, functional and biochemical variables associated with reduced bone mineral 
density (BMD). 
Patients and methods: BMD of the lumbar spine (L2-L4) was examined in 
26 patients with CF aged 2 22 years using dual energy X-ray absorptiometry. 
Anthropometric variables, disease severity, pulmonary function, exercise capacity, 
serum calcium, phosphate, 25(OH)vitamin D, C-end telopeptides, osteocalcin levels, 
gonadal hormones concentration were assessed and related to BMD. 
Results: In 34.6% patients using the tables of conjugated values of anthropometric 
and densitometric indices BMD was significantly reduced. Z-score was 1.8±0.93 
SD of normal values and correlated with the body mass index, and the Shwachman 
score. Forced expiratory volume in 1 second, vital capacity, exercise capacity were 
lower, residual volume higher in children with osteopenia. The serum levels of 
calcium and 25(OH)vitamin D were lower than normal in 39% and 48% cases 
respectively, but there was no significant difference in children with normal and 
reduced BMD. Urine calcium excretion was decreased in 57% cases and related 
with bone mass and BMD. Serum C-end telopeptides levels were elevated in 72.7% 
patients. Osteocalcin were decreased in 63.6% cases. Testosterone and oestradiol 
deficiency was determined in 61.1% of males and 42.8% females respectively, but 
decreased BMD did not correlate with lowered gonadal hormones concentration. 
Conclusion: Osteopenia is frequently observed in CF patients. Nutrition status, 
disease severity are factors most highly correlated with decreased BMD. The dual 
X-ray absorptiometry should be an integral part of investigation i CF subjects in 
order to prevent and treat osteoporosis. 
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~The retrospective assessment of bone mass density in patients 
with Cystic Fibrosis 
A. Minarowska 1 , J. Konstantynowicz 2, M. Kaczmarski 1 , L. Minarowski 3. 
13rd Dept. of Children ~' Diseases, 2Dept. of Pediatrics and Growth Development, 
3public Clinical Hospital of Medical University of Bialystok, Poland 
Regarding the lifestyle quality handicap associated with CF, limited spontaneous 
mobility and application of steroidtherapy, there is a potential disorder of bone 
tissue mineralization. 
Aims; the aim was the retrospective (annual), quantitative assessment of bone mass 
density change in patients with cystic fibrosis and assessment of prophylaxis in 
cases with osteopenia nd osteoporosis. 
Methods; The study was performed in group of 21 CF patients (8F, 13M) aged 
3 24yrs. Total bone mineral density and lumbar spine bone mineral density of 
L2-L4 region was evaluated. Obtained results were expressed as Z-scores. The 
results were also presented using the authentic method of percentiles. Osteopenia 
was assumed when the BMD was <ISD and osteoporosis when <2SD. Values 
of total BMD below 5th perc. were equivalent to osteopenia. In all patients daily 
supplementation ofvit.D3 (800 units) and calcium (800 1200mg) was provided. 
Results; In 4 females (50%) Z-score BMD SPINE was <2SD which equals 
values <5%. In 5 males (38.5%) Z-score BMD SPINE was below 2SD which 
was at 5th perc. and below, and in 5 males (38.5%) BMD SPINE was below 1SD 
indicating osteopenia. In annual evaluation only in one female and in one male 
the BMD SPINE values had an increasing trend and were within normal percentile 
values. 
Conclusions; The calcium supplementation in CF patients is necessary but not 
always sufficient. In the advanced cases of CF related osteoporosis other the use 
of other confections should be considered and assessed. The annual assessment of 
total and lumbar bone mass density is essential for therapy modification. 
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Despite the advances in clinical and nutritional treatments of CFR complications 
such reduction of the BMD are described. 
The objective of this study was to evaluate BMD in CFR A transversal descriptive 
study at the University Hospital was done. CFP older than 10 years were selected. 
Nutritional status was assessed by anthropometrics ndices weight/age, height/age 
and body mass index (kg/m2). Lumbar spine BMD (segment L2-L4), femur and 
whole body were evaluated by a dual-energy x-ray absorptiometry (DEXA). This 
exam also allows the measurement of both lean and fat mass (kg). The dietary food 
intake and pulmonary function test was determined. Mean age (14.4±3.85 years) 
male (58.6%). The weight/age and height/age Z-scores demonstrated malnutrition: 
60.9% and 65.2%, respectively. The evaluation of bone densitometry determined 
that 58.6% of the patients had reduced bone mineral density at the lumbar spine and 
42.3% of them had it on the entire body. There was a positive correlation between 
BMD of lumbar spine, femur and whole body and age, body mass index and 
lean mass (p < 0.05). The pulmonary disease severity and pancreatic insufficiency 
present no association with BMD. The dietary food intake revealed adequate values 
for nutrients that were beyond a 100% of the European Consensus on Cystic Fibrosis 
recommendation. 
Conclusion; The results on this study demonstrated a significant change in BMD 
and this finds are in concordance to the scientific literature. The maintenance of an 
adequate nutritional status may guarantee effective protection for bone mass loss 
at the lumbar spine and at the whole body. A prevention bone mineralization is 
important in CF patients because it might reduce fracture risk. 
• Serum phospholipid fatty acid pattern is associated with 
bone growth in children but not adults with Cystic Fibrosis 
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Essential fatty acids (EFA) have proved to be important for normal bone mineral 
density (BMD) and bone growth in animal studies. Patients with cystic fibrosis (CF) 
often have low serum EFA levels. The aim of the study was to analyse if BMD was 
related to FA status in patients with CE 
Methods: Bone mass was studied prospectively in patients with CF, aged 6~3 yrs 
(35 children and 19 adults), during a two-year period (Gronowitz et al. Pediatrics 
2004; 114: 435). BMD was measured with dual x-ray absorptiometry, and FA 
concentrations in serum phospholipids were determined with capillary gas-liquid 
chromatography (J Lipid Res 2001; 42: 359) 
Results: The CF patients howed low linoleic acid concentration a d high ratio of 
arachidonic acid (AA) to docosahexaenoic acid (DHA) in serum in both children 
and adults compared to healthy controls. The ratio of eicosatrienoic acid (ETA) 
and AA, an index of EFA deficiency, was high and increased further during two 
years in the children, as did the total concentration f saturated FA. Bone mineral 
content in lumbar spine (LS) and femoral neck (FN) were positively correlated to 
the most common saturated FA, palmitic acid only in the children with CF, r 0.6, 
p 0.0001 and r 0.5, p 0.001, respectively. The LS BMD z-score and change 
in z-score correlated negatively to the AA/DHA ratio in children (both r 0.4, 
p 0.004 and 0.02, respectively), but not in adults. The EFA deficiency index was 
positively correlated to the bone area of LS (p < 0.01) and FN (p < 0.001) in both 
children and adults. 
Conclusion: Our results imply that FA status influenced bone growth in CF children, 
but not in adults, suggesting that FA status would be important for bone modelling 
but not for bone remodelling. 
